VENBECLA Canadian Trademark Information

On Monday, June 29, 2015, a canadian trademark registration was filed for VENBECLA by AbbVie Manufacturing Managemen *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1735084. The current status of this trademark filing is Registration published. The VENBECLA trademark is filed in the description of Pharmaceutical preparations for the treatment of viral diseases and infections, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), Human Immunodeficiency Virus (HIV), metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism, endocrine diseases and infections, namely, growth and thyroid disorders, musculoskeletal system diseases and infections, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, and cartilage injuries, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, namely, hypertension, stroke, and coronary heart disease, genitourinary diseases and disorders, namely, urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases, sexual dysfunction, oncological diseases and disorders, hepatological diseases and disorders, namely, blood disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, namely, brain injury, spinal cord injury, seizure disorders, Huntington's Disease, cerebral palsy, and Alzheimer's, gastrointestinal diseases and disorders, hormonal diseases and disorders, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, and thyroid hormone preparations, dermatological diseases and disorders, namely, dermatitis, eczema, and psoriasis, psychiatric diseases and disorders, namely, anxiety, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis and seizures and immune system related diseases and disorders, namely, immunosuppressants, autoimmune diseases and disorders and immunologic deficiency syndrome , Pharmaceutical preparations for the treatment of viral diseases and infections, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), Human Immunodeficiency Virus (HIV), metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism, endocrine diseases and infections, namely, growth and thyroid disorders, musculoskeletal system diseases and infections, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, and cartilage injuries, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, namely, hypertension, stroke, and coronary heart disease, genitourinary diseases and disorders, namely, urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases, sexual dysfunction, oncological diseases and disorders, hepatological diseases and disorders, namely, blood disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, namely, brain injury, spinal cord injury, seizure disorders, Huntington's Disease, cerebral palsy, and Alzheimer's, gastrointestinal diseases and disorders, hormonal diseases and disorders, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, and thyroid hormone preparations, dermatological diseases and disorders, namely, dermatitis, eczema, and psoriasis, psychiatric diseases and disorders, namely, anxiety, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis and seizures and immune system related diseases and disorders, namely, immunosuppressants, autoimmune diseases and disorders and immunologic deficiency syndrome .